Drugs / AS2-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003475 | Feb 1996 → May 2011 | brain cancer | Burzynski Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS2-1 | “A10 (Atengenal); AS2-1 (Astugenal)” NCT00003475 ↗ |
| Known as | Astugenal | “A10 (Atengenal); AS2-1 (Astugenal)” NCT00003475 ↗ |
| Route | Intravenous | “by IV infusion” NCT00003475 ↗ |